Can Ebola Fears Deliver a Value Opportunity in the Cruise Industry?

by Tom Sandford

For a lesson on smooth sailing into global markets, one only needs to look at the global cruise industry. In just the last decade, the number of cruise passengers has jumped by 77% from 12 million to 21.3 million, according to the Cruise Lines International Organization. But there’s one region they’re avoiding: West Africa.

Read article »

Is October the Month for Technology Stocks?

by David Becker

Technology stocks generally perform well in October as investors begin to focus on third quarter earnings. While the group as a whole has outperformed the broader markets, there are a number of both software and hardware companies that have experienced stellar performance.

Read article »

Podcast: Chrysler Returns, HBO Cuts the Cord and Ireland Fights Inversion

by Alexander Moschina

Welcome back to our weekly wrap-up of financial news. In case you haven’t noticed, we’ve undergone a major format change: Investment U #Trending the column is now Investment U #Trending the podcast.

Read article »

Latest Articles

Chart of the Week: Can You Afford Retirement?

by Rachel Gearhart

It’s recommended that workers shoot for a retirement income of at least 70% of their pre-retirement income. Yet on average, retiree households in the United States are living on only $37,847 a year. According to an study of 2013 Census Bureau data, that’s only 60% of the annual income of 45- to 64-year-olds. Read On…

Plus 3 Things You Must Know About Oil Prices

by Sean Brodrick

Oil prices recently dropped to four-year lows. You can bet there are Texas oil men shaking in their 10-gallon hats right now, wondering if oil will go to $80... $75... or lower. The short-term action in oil prices is hard to predict. But here are three things you must know when you're making plans for your own energy investments. Read On…

Plus What’s Wrong With This Market?

by Alexander Green

Over the last two months, the S&P 500 has gone from a double-digit gain for the year into the red. Small cap stocks, as measured by the Russell 2000 index, have gone from a correction (a decline of 10% or more) into almost bear market territory (a decline of 20% or more). What's wrong with this market? Less than you might think. But let's start with the negatives. Read On…

Plus The Best Strategy for Dealing With the Market Sell-Off

by Marc Lichtenfeld

Investors have it tough today. The market has been ugly the past few weeks, instilling fear in some investors that the bull market is over and they missed their chance at making money. Additionally, interest rates are still so low, it's tough to generate any income from your nest egg. However, the recent market slide is a perfect opportunity for investors who know how to pick up extra cash with a conservative strategy. Read On…

Plus Technical Tuesday: When There’s Blood in the Streets

by Christopher Rowe

Baron Nathan Rothschild is credited with saying: "Buy when there's blood in the streets." Rothschild meant that investors should buy stocks when the bulls are getting their flesh ripped off by the bears. But would a man of this stature really wager a fortune by courageously stepping in front of a wave of stock market fear and buying? Not exactly. Read On…

Plus Your Most Important Tax Savings This Year

by Alexander Green

You have to give the government high marks for thoroughness. They tax you when you earn it, when you save it, when you invest it and when you spend it. When you die, they tax what's left over. Fortunately, you have a legal right to minimize what the government takes. Read On…

Is the $33 Billion Firearm Manufacturing Industry Recoiling?

by Tom Sandford

Emotion can have a huge effect on stock prices. For example, consider the stock price of firearm maker Sturm, Ruger & Co. (NYSE: RGR). Its stock has increased by 1,500% since President Barack Obama was sworn into office. Coincidence? Hardly. As the election wrapped up, gun sales went the opposite direction. Read On…

Investors Get Bullish on Ebola Cure Stocks

by Tom Sandford

​On September 30, the Centers for Disease Control and Prevention announced the first confirmed case of Ebola in the U.S. The disease has sickened more than 8,000 people since it flared up in Africa earlier this year, and more than 3,800 have died. One bright spot, however, is that it put cure-developing companies in the spotlight. In fact, the CDC’s announcement sent select biotech stocks soaring. Read On…

Live Twitter Feed